Newsroom
October 3, 2024
Approximately 30% of individuals with myeloid malignancy diseases have a mutation in a certain gene called tet methylcytosine dioxygenase 2 (TET2). This gene is responsible for providing instructions on creating certain proteins and is known to have a tumor-suppressive function. A study published October 2 in Nature is the first to explain the pathway […]
October 1, 2024
Pancreatic ductal adenocarcinoma (PDAC), a certain type of pancreatic cancer, is a ruthless killer with an average five-year survival rate of less than 10%. Most patients are diagnosed at a late stage when the cancer has already spread throughout their bodies. And the problem is only growing worse. By 2030, pancreatic cancer is expected […]
September 30, 2024
Charles P. France, PhD, to lead methocinnamox drug development program The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was awarded a $12 million cooperative agreement (U01) from the National Institutes of Health’s National Institute on Drug Abuse to further develop methocinnamox (MCAM) as a treatment for opioid use disorder. […]
September 30, 2024
Guy Nicolette, MD, associate clinical professor, Department of Orthopaedics, and lead sports medicine physician for the San Antonio Spurs, was quoted in this article. Read More
September 30, 2024
Join UT Health San Antonio and The University of Texas at San Antonio as they celebrate health care workers during the Roadrunner’s Oct. 19 football game. As part of the UTSA Athletics Salute to Hometown Heroes initiative, UT Health San Antonio dignitaries will recognize the unwavering commitment of health care workers at the homecoming […]
September 26, 2024
Dean Kellogg Jr., MD, PhD, professor of medicine and geriatrics, and Adam Salmon, PhD, professor of molecular medicine and associate director of the Sam and Ann Barshop Institute for Longevity and Aging Studies, were quoted in this article. Read More